PRP Injections Show Promise for Shoulder Arthritis Pain Relief

Ain Shams University researchers completed a clinical trial investigating platelet-rich plasma (PRP) therapy for shoulder osteoarthritis, a degenerative joint condition causing significant pain and functional limitations. The study enrolled 91 participants experiencing shoulder arthritis symptoms that interfere with daily activities and quality of life.

The intervention involved injecting PRP directly into the glenohumeral joint space of the shoulder. PRP is created by concentrating platelets from the patient's own blood, which contain growth factors and healing proteins that may stimulate tissue repair and reduce inflammation in damaged cartilage and surrounding structures.

The trial ran from March to August 2021, spanning approximately five months of treatment and follow-up. This timeframe allowed researchers to assess both immediate and sustained effects of the PRP intervention on pain levels, joint function, and overall shoulder mobility.

As a regenerative medicine approach, PRP therapy represents a shift from symptom management toward addressing underlying tissue damage. Unlike corticosteroid injections that primarily reduce inflammation temporarily, PRP aims to promote actual healing of deteriorated joint structures. This distinction is particularly relevant for longevity-focused healthcare, as preserving joint function becomes increasingly important for maintaining independence and physical activity levels throughout aging. The completion of this trial adds to growing evidence for regenerative therapies that may help individuals maintain musculoskeletal health longer, potentially reducing the need for more invasive interventions like joint replacement surgery.